|Bid||26.10 x 800|
|Ask||26.95 x 900|
|Day's Range||26.27 - 28.38|
|52 Week Range||24.75 - 57.00|
|Beta (5Y Monthly)||0.54|
|PE Ratio (TTM)||17.36|
|Earnings Date||Jan 17, 2022 - Jan 21, 2022|
|Forward Dividend & Yield||1.20 (4.43%)|
|Ex-Dividend Date||Aug 05, 2021|
|1y Target Est||27.00|
PetMed Express (NASDAQ: PETS) is at the intersection of at least three hot emerging trends. PetMed Express should also be a beneficiary of consumers shifting to the convenience of home delivery over brick-and-mortar shopping trips. Unfortunately for PetMed Express investors, its fundamentals seem to have missed the memo.
View more earnings on PETSSee more from BenzingaClick here for options trades from BenzingaB. Riley Sees 'Significant Potential' In This Beaten-Up Biotech StockVentyx Jumps Over 20% Today After NASDAQ Debut© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Welcome to the PetMed's Conference Call to review the Financial Results for the Second Fiscal Quarter ended on September 30, 2021. Founded in 1996 PetMeds is become America's most trusted pet pharmacy delivering prescription and non-prescription pet medications and other health products for the dogs, cats and horses direct to the customer. PetMed's markets its products through national advertising campaigns with direct customers to order by phone or on the Internet to increase the recognition of the PetMed's branding.